BAJAJ BROKING

Notification
No new Notification messages
Inventurus Knowledge Solutions IPO is Open!
Apply for the Inventurus Knowledge Solutions IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
ajanta pharma limited stock

AJANTA PHARMA LIMITED Share Price

2807.45 -31.50 (-1.10%)
Dec 13 2024 03:30 PM Pharmaceuticals NSE: AJANTPHARM

AJANTA PHARMA LIMITED Share Price Update

As of the latest trading session, AJANTA PHARMA LIMITED share price is currently at 2807.45, which is down by -31.50 from its previous closing. Today, the stock has fluctuated between 2775.15 and 2861.55. Over the past year, AJANTA PHARMA LIMITED has achieved a return of 47.58 %. In the last month alone, the return has been -0.61 %. Read More...

AJANTA PHARMA LIMITED Performance

Day Range

Low2775.15 High2861.55
2807.45

52 Week Range

Low 1850.25 High 3485.00
2807.45

AJANTA PHARMA LIMITED Share Price

8124

532331

AJANTPHARM

img img img img
No Data Available

Open Price

2850.00

Prev. Close

2838.95

Volume (Shares)

67248.00

Total traded value

1887.95

Upper Circuit

3406.70

Lower Circuit

2271.20

Note: The current prices & values are delayed, Login to your account for live updates.

AJANTA PHARMA LIMITED Fundamentals


(Standalone)

Market Cap (Cr) 35349.91
PE Ratio (TTM) 41.05
Book Value / Share 282.55
Beta 0.24
ROE 24.24%
EPS (TTM) 68.36
Dividend Yield 1.84%
Net Profit Qtr (Cr) 234.98

AJANTA PHARMA LIMITED Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 1128.91
Operating Expense 860.05
Net Profit 234.98
Net Profit Margin (%) 20.81
Earnings Per Share (EPS) 18.75
EBITDA 343.25
Effective Tax Rate (%) 24.00
Particulars JUN 2024 (Values in Cr)
Revenue 1077.27
Operating Expense 795.08
Net Profit 236.03
Net Profit Margin (%) 21.91
Earnings Per Share (EPS) 18.77
EBITDA 344.20
Effective Tax Rate (%) 23.99
Particulars MAR 2024 (Values in Cr)
Revenue 926.07
Operating Expense 733.81
Net Profit 162.69
Net Profit Margin (%) 17.56
Earnings Per Share (EPS) 12.92
EBITDA 260.83
Effective Tax Rate (%) 27.99
Particulars DEC 2023 (Values in Cr)
Revenue 1085.29
Operating Expense 793.88
Net Profit 220.15
Net Profit Margin (%) 20.28
Earnings Per Share (EPS) 17.48
EBITDA 340.90
Effective Tax Rate (%) 27.85
Particulars SEP 2023 (Values in Cr)
Revenue 945.18
Operating Expense 706.84
Net Profit 212.36
Net Profit Margin (%) 22.46
Earnings Per Share (EPS) 16.87
EBITDA 325.81
Effective Tax Rate (%) 26.89
Particulars MAR 2024 (Values in Cr)
Revenue 3971.12
Operating Expense 2990.65
Net Profit 807.24
Net Profit Margin (%) 20.32
Earnings Per Share (EPS) 64.11
EBITDA 1235.91
Effective Tax Rate (%) 26.41
Particulars MAR 2023 (Values in Cr)
Revenue 3411.27
Operating Expense 2844.17
Net Profit 558.72
Net Profit Margin (%) 16.37
Earnings Per Share (EPS) 43.61
EBITDA 832.03
Effective Tax Rate (%) 20.16
Particulars MAR 2022 (Values in Cr)
Revenue 3140.64
Operating Expense 2379.83
Net Profit 719.86
Net Profit Margin (%) 22.92
Earnings Per Share (EPS) 55.52
EBITDA 1030.62
Effective Tax Rate (%) 20.06
Particulars MAR 2021 (Values in Cr)
Revenue 2718.59
Operating Expense 1920.07
Net Profit 675.64
Net Profit Margin (%) 24.85
Earnings Per Share (EPS) 77.59
EBITDA 1020.48
Effective Tax Rate (%) 25.10
Particulars MAR 2020 (Values in Cr)
Revenue 2196.42
Operating Expense 1764.03
Net Profit 441.13
Net Profit Margin (%) 20.08
Earnings Per Share (EPS) 50.55
EBITDA 713.06
Effective Tax Rate (%) 27.99
Particulars MAR 2024 (Values in Cr)
Book Value / Share 282.34
ROE % 23.47
ROCE % 31.59
Total Debt to Total Equity 0.01
EBITDA Margin 29.86
Particulars MAR 2023 (Values in Cr)
Book Value / Share 268.14
ROE % 17.68
ROCE % 22.21
Total Debt to Total Equity 0.01
EBITDA Margin 23.56
Particulars MAR 2022 (Values in Cr)
Book Value / Share 380.24
ROE % 22.77
ROCE % 28.91
Total Debt to Total Equity 0.01
EBITDA Margin 31.28
Particulars MAR 2021 (Values in Cr)
Book Value / Share 344.52
ROE % 23.38
ROCE % 31.64
Total Debt to Total Equity 0.02
EBITDA Margin 35.46
Particulars MAR 2020 (Values in Cr)
Book Value / Share 296.34
ROE % 19.31
ROCE % 27.10
Total Debt to Total Equity 0.02
EBITDA Margin 29.82
Particulars MAR 2024 (Values in Cr)
Book Value / Share 270.17
ROE % 24.24
ROCE % 32.49
Total Debt to Total Equity 0.01
EBITDA Margin 31.12
Particulars MAR 2023 (Values in Cr)
Book Value / Share 256.94
ROE % 17.42
ROCE % 21.63
Total Debt to Total Equity 0.01
EBITDA Margin 24.39
Particulars MAR 2022 (Values in Cr)
Book Value / Share 369.15
ROE % 23.78
ROCE % 29.60
Total Debt to Total Equity 0.01
EBITDA Margin 32.82
Particulars MAR 2021 (Values in Cr)
Book Value / Share 331.80
ROE % 25.28
ROCE % 33.43
Total Debt to Total Equity 0.01
EBITDA Margin 37.54
Particulars MAR 2020 (Values in Cr)
Book Value / Share 280.65
ROE % 19.17
ROCE % 26.68
Total Debt to Total Equity 0.01
EBITDA Margin 32.46
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 130.77
Total Assets 4638.39
Total Liabilities 4638.39
Total Equity 3567.36
Share Outstanding 125914655
Price to Book Ratio 8.28
Return on Assets (%) 17.59
Return on Capital (%) 22.87
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 330.90
Total Assets 4679.02
Total Liabilities 4679.02
Total Equity 3387.99
Share Outstanding 125914655
Price to Book Ratio 4.71
Return on Assets (%) 12.56
Return on Capital (%) 17.35
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 211.79
Total Assets 4055.58
Total Liabilities 4055.58
Total Equity 3264.34
Share Outstanding 85415770
Price to Book Ratio 4.90
Return on Assets (%) 17.57
Return on Capital (%) 21.82
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 209.61
Total Assets 3778.72
Total Liabilities 3778.72
Total Equity 2995.63
Share Outstanding 86531770
Price to Book Ratio 5.40
Return on Assets (%) 17.30
Return on Capital (%) 21.82
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 205.25
Total Assets 3318.69
Total Liabilities 3318.69
Total Equity 2598.87
Share Outstanding 87261270
Price to Book Ratio 4.87
Return on Assets (%) 14.09
Return on Capital (%) 17.7
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 63.06
Total Assets 4217.44
Total Liabilities 4217.44
Total Equity 3413.57
Share Outstanding 125914655
Price to Book Ratio 8.28
Return on Assets (%) 19.14
Return on Capital (%) 23.65
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 269.92
Total Assets 4304.79
Total Liabilities 4304.79
Total Equity 3246.45
Share Outstanding 125914655
Price to Book Ratio 4.71
Return on Assets (%) 12.97
Return on Capital (%) 17.21
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 145.25
Total Assets 3780.49
Total Liabilities 3780.49
Total Equity 3169.18
Share Outstanding 85415770
Price to Book Ratio 4.90
Return on Assets (%) 19.04
Return on Capital (%) 22.71
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 151.98
Total Assets 3532.06
Total Liabilities 3532.06
Total Equity 2884.98
Share Outstanding 86531770
Price to Book Ratio 5.40
Return on Assets (%) 19.12
Return on Capital (%) 23.42
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 87.85
Total Assets 3049.15
Total Liabilities 3049.15
Total Equity 2461.30
Share Outstanding 87261270
Price to Book Ratio 4.87
Return on Assets (%) 14.46
Return on Capital (%) 17.92
Particulars MAR 2024 (Values in Cr)
Net Income 1113.93
Cash from Operations 1097.20
Cash from Investing 65.39
Cash from Financing -1051.06
Net change in Cash -200.60
Free Cash Flow 1249.61
Particulars MAR 2023 (Values in Cr)
Net Income 745.25
Cash from Operations 943.40
Cash from Investing -559.60
Cash from Financing -108.20
Net change in Cash 124.31
Free Cash Flow 1117.88
Particulars MAR 2022 (Values in Cr)
Net Income 909.48
Cash from Operations 800.84
Cash from Investing -74.10
Cash from Financing -459.71
Net change in Cash 27.90
Free Cash Flow 949.68
Particulars MAR 2021 (Values in Cr)
Net Income 900.18
Cash from Operations 806.70
Cash from Investing -282.38
Cash from Financing -318.29
Net change in Cash -24.36
Free Cash Flow 978.31
Particulars MAR 2020 (Values in Cr)
Net Income 663.97
Cash from Operations 611.60
Cash from Investing -224.40
Cash from Financing -128.63
Net change in Cash 103.74
Free Cash Flow 851.02
Particulars MAR 2024 (Values in Cr)
Net Income 1096.95
Cash from Operations 987.63
Cash from Investing 105.02
Cash from Financing -1047.70
Net change in Cash -207.33
Free Cash Flow 1140.20
Particulars MAR 2023 (Values in Cr)
Net Income 699.85
Cash from Operations 861.85
Cash from Investing -501.31
Cash from Financing -105.12
Net change in Cash 129.86
Free Cash Flow 1037.51
Particulars MAR 2022 (Values in Cr)
Net Income 900.54
Cash from Operations 735.81
Cash from Investing -66.04
Cash from Financing -457.30
Net change in Cash 19.00
Free Cash Flow 882.33
Particulars MAR 2021 (Values in Cr)
Net Income 902.09
Cash from Operations 664.90
Cash from Investing -162.68
Cash from Financing -268.90
Net change in Cash 35.41
Free Cash Flow 831.87
Particulars MAR 2020 (Values in Cr)
Net Income 612.67
Cash from Operations 439.41
Cash from Investing -115.91
Cash from Financing -134.00
Net change in Cash 50.97
Free Cash Flow 675.78
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 64.13 36.86 3.50 491.45 37.54 / 77.70
BLISS GVS PHARMA LTD 175.85 22.01 1.83 1852.87 92.25 / 179.65
CIPLA LTD 1447.35 25.32 4.12 116889.80 1192.85 / 1702.00
FERMENTA BIOTECH LIMITED 403.70 140.17 4.09 1188.13 145.00 / 440.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 64.13 55.77 10.90 491.45 37.54 / 77.70
AMRUTAJAN HEALTH LTD 749.90 45.61 7.28 2168.01 556.05 / 861.40
ASTRAZENECA PHARMA IND LT 6603.60 128.25 24.30 16509.00 4050.15 / 8139.85
BLISS GVS PHARMA LTD 175.85 22.93 1.80 1852.87 92.25 / 179.65

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 2824.30
  • 26 Days 2929.90
  • 10 Days 2874.30
  • 50 Days 3004.20
  • 12 Days 2885.90
  • 100 Days 2924.70
  • 20 Days 2885.10
  • 200 Days 2218.70
2834.92
PIVOT
First Resistance 2879.78
Second Resistance 2920.62
Third Resistance 2965.48
First Support 2794.08
Second Support 2749.22
Third Support 2708.38
RSI 38.52
MACD -44.00
Commodity Channel Index (CCI) -109.59
ADX 20.12
Williams % R -81.78

Over 1 Month

down

-0.61

Over 3 Months

down

-15.57

Over 6 Months

down

15.99

Over 1 Year

down

47.58

Over 3 Years

down

25.12

Over 5 Years

down

33.86

AJANTA PHARMA LIMITED Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

AJANTA PHARMA LIMITED Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Public
7.52
Promoter Holdings
66.25
FII
9.11
DII
17.1
Promoter Shares(Pledge Percentage)
11.17
Name Category Shares Shares%
Yogesh M Agrawal, Trustee Yogesh Agrawal Trust Shareholding of Promoter and Promoter Group 1.8078147E7 14.47
Rajesh M Agrawal, Trustee Rajesh Agrawal Trust Shareholding of Promoter and Promoter Group 1.8078148E7 14.47
Ravi P Agrawal, Trustee Ravi Agrawal Trust Shareholding of Promoter and Promoter Group 1.6242904E7 13.0
Aayush M Agrawal, Trustee Aayush Agrawal Trust Shareholding of Promoter and Promoter Group 1.4112924E7 11.3
Gabs Investments Pvt Ltd Shareholding of Promoter and Promoter Group 1.2588393E7 10.08
Nippon Life India Trustee Ltd-a/c Nippon India Small Cap Fund Public Shareholding 3723535.0 2.98
Uti Flexi Cap Fund Public Shareholding 3682565.0 2.95
Ganga Exports Being Represented By Yogesh Agrawal, Rajesh Agrawal & Ravi Agrawal Shareholding of Promoter and Promoter Group 3348261.0 2.68
Hdfc Large And Mid Cap Fund Public Shareholding 1918366.0 1.54
Tata Aia Life Insurance Co Ltd-whole Life Mid Cap Equity Fund-ulif 009 04/01/07 Wle 110 Public Shareholding 1675670.0 1.34
Kotak Small Cap Fund Public Shareholding 1548935.0 1.24
Aditya Birla Sun Life Trustee Private Limited A/c Aditya Birla Sun Life Equity Advantage Fund Public Shareholding 1307947.0 1.05
Canara Robeco Mutual Fund A/c Canara Robeco Small Cap Fund Public Shareholding 1288221.0 1.03
Ravi P Agrawal Shareholding of Promoter and Promoter Group 285000.0 0.23
Aayush M Agrawal Shareholding of Promoter and Promoter Group 30000.0 0.02
Mannalal B. Agrawal Shareholding of Promoter and Promoter Group 0.0 0.0

AJANTA PHARMA LIMITED

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2024-02-08 26.0 Interim 2 2024-02-08 Equity shares 2023-08-04 15.0 Special 2023-08-04 Equity shares 2023-08-04 10.0 Interim 1 2023-08-04 Equity shares 2022-11-11 7.0 Interim 2022-11-14 Equity shares 2021-11-09 9.5 Interim 2021-11-10 Equity shares 2020-11-12 9.5 Interim 2020-11-13 Equity shares 2019-11-15 13.0 Interim 2019-11-18 Equity shares 2018-11-09 9.0 Interim 2018-11-12 Equity shares 2017-03-23 7.0 Interim 2 2017-03-25 Equity shares 2016-11-07 6.0 Interim 2016-11-08 Equity shares 2016-03-17 8.0 Interim 2016-03-19 Equity shares 2015-06-25 6.0 Final 2015-06-27 Equity shares 2014-07-24 10.0 Final 2014-07-28 Equity shares 2013-07-18 6.25 Final 2013-07-22 Equity shares 2012-06-28 7.5 Final 2012-07-02 Equity shares 2011-06-23 5.0 Final 2011-06-25 Equity shares 2010-06-29 3.5 Final 2010-07-01 Equity shares 2009-06-30 2.5 Final 2009-07-03 Equity shares 2008-06-27 2.5 Final 2008-07-01 Equity shares 2007-09-19 2.0 Final 2007-09-21 Equity shares
Ex-Date Ex-Bonus Ratio
2022-06-23 2022-06-22 1:2 2013-09-18 2013-09-17 1:2
Ex-Date Old FV NEW FV Record Date
2015-03-20 5.0 2.0 2015-03-23 2012-08-09 10.0 5.0 2012-08-10

Learn More About Stocks

About AJANTA PHARMA LIMITED

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by AJANTA PHARMA LIMITED

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Ajanta Pharma Ltd?

Answer Field

The share price of Ajanta Pharma Ltd for NSE is ₹ 2807.45 and for BSE is ₹ 2806.5.

What is the Market Cap of Ajanta Pharma Ltd?

Answer Field

The market cap of Ajanta Pharma Ltd for NSE is ₹ 3,53,49.91 Cr. and for BSE is ₹ 3,53,37.95 Cr. as of now.

What is the 52 Week High and Low of Ajanta Pharma Ltd?

Answer Field

The 52 Week High and Low of Ajanta Pharma Ltd for NSE is ₹ 3485.00 and ₹ 1850.25 and for BSE is ₹ 3485.75 and ₹ 1852.55.

How to Buy Ajanta Pharma Ltd share?

Answer Field

You can trade in Ajanta Pharma Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Ajanta Pharma Ltd?

Answer Field

The 1 year returns on the stock has been 47.58%.

What is the Current Share Price of Ajanta Pharma Ltd?

Answer Field

Ajanta Pharma Ltd share price is for NSE ₹ 2807.45 & for BSE ₹ 2806.5 as on Dec 13 2024 03:30 PM.

What is the Market Cap of Ajanta Pharma Ltd Share?

Answer Field

The market cap of Ajanta Pharma Ltd for NSE ₹ 3,53,49.91 & for BSE ₹ 3,53,37.95 as on Dec 13 2024 03:30 PM.

What is the P/E Ratio of Ajanta Pharma Ltd Share?

Answer Field

As on Dec 13 2024 03:30 PM the price-to-earnings (PE) ratio for Ajanta Pharma Ltd share is 41.05.

What is the PB ratio of Ajanta Pharma Ltd Share?

Answer Field

As on Dec 13 2024 03:30 PM, the price-to-book (PB) ratio for Ajanta Pharma Ltd share is 282.55.

How to Buy Ajanta Pharma Ltd Share?

Answer Field

You can trade in Ajanta Pharma Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Ajanta Pharma Ltd Share on Bajaj Broking App?

Answer Field

To buy Ajanta Pharma Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Ajanta Pharma Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs+ Users

icon-with-text

4.4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4700+ Cr MTF Book

icon-with-text
loader